I don’t impose such a restriction—Zebra’s Law, as originally posited (#msg-23784371) applies to a company’s lead program regardless of how many other programs are behind it in the pipeline.
Rindo is technically CLDX's lead program, not CDX-011, but I think 011 has more promise so point taken. I do think the promising results in TN/HG make it unlikely Zebra's Law will be at play here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.